Patents by Inventor Karl Erik Goeran GANNEDAHL

Karl Erik Goeran GANNEDAHL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION COMPRISING AN OMEGA-3 FATTY ACID COMPOSITION AND AN SGLT2 INHIBITOR
    Publication number: 20180021359
    Abstract: A method for treating NAFLD and/or NASH and suitable compositions for carrying out the method are claimed.
    Type: Application
    Filed: August 9, 2017
    Publication date: January 25, 2018
    Applicant: AstraZeneca AB
    Inventor: Karl Erik, Goeran GANNEDAHL
  • Combination comprising an omega-3 fatty acid composition and an SGLT2 inhibitor
    Patent number: 9757404
    Abstract: A method for treating NAFLD and/or NASH and suitable compositions for carrying out the method are claimed.
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: September 12, 2017
    Assignee: ASTRAZENECA AB
    Inventor: Karl Erik Goeran Gannedahl
  • METHOD OF TREATMENT
    Publication number: 20160113953
    Abstract: A method for treating NAFLD and/or NASH and suitable compositions for carrying out the method are claimed.
    Type: Application
    Filed: September 24, 2015
    Publication date: April 28, 2016
    Applicant: ASTRAZENECA AB
    Inventor: Karl Erik Goeran GANNEDAHL